In a statement, ByHeart, a company based in New York City, said it was informed on Nov. 7 that the FDA had identified about 83 cases of infant botulism nationwide since August, with 13 involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback